Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael K Brawer

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Reviews in Urology|September 21, 2006
Prostatic intraepithelial neoplasia: an overviewMichael K Brawer
Reviews in Urology|September 21, 2006
Androgen supplementation and prostate cancer risk: strategies for pretherapy assessment and monitoringMichael K Brawer
Reviews in Urology|September 21, 2006
Assays for complexed prostate-specific antigen and other advances in the diagnosis of prostate cancerMichael K Brawer
Reviews in Urology|October 6, 2006
Hormonal therapy for prostate cancerMichael K Brawer
Reviews in Urology|September 21, 2006
Selecting treatment for high-risk, localized prostate cancer: the case for radiation therapyRobert Meier, Michael K Brawer
Reviews in Urology|September 21, 2006
High-grade prostatic intraepithelial neoplasiaDavid G Bostwick, Lina Liu, Michael K Brawer, et al.
BJU International|June 26, 2004
Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSAJ Kellogg Parsons, Michael K Brawer, Carol D Cheli, et al.
Urology|April 19, 2005
Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening programAl Baha Barqawi, Brian K Golden, Colin O'Donnell, et al.
Reviews in Urology|September 21, 2006
Chemoprevention strategies in the prostate: an overviewGary J Kelloff, Howard R Higley, Michael K Brawer, et al.
The Journal of Urology|October 22, 2011
Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancerMatthew R Smith, S Bruce Malkowicz, Michael K Brawer, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Reviews in Urology|September 21, 2006
Prostatic intraepithelial neoplasia: an overviewMichael K Brawer
Reviews in Urology|September 21, 2006
Androgen supplementation and prostate cancer risk: strategies for pretherapy assessment and monitoringMichael K Brawer
Reviews in Urology|September 21, 2006
Assays for complexed prostate-specific antigen and other advances in the diagnosis of prostate cancerMichael K Brawer
Reviews in Urology|October 6, 2006
Hormonal therapy for prostate cancerMichael K Brawer
Reviews in Urology|September 21, 2006
Selecting treatment for high-risk, localized prostate cancer: the case for radiation therapyRobert Meier, Michael K Brawer
Reviews in Urology|September 21, 2006
High-grade prostatic intraepithelial neoplasiaDavid G Bostwick, Lina Liu, Michael K Brawer, et al.
BJU International|June 26, 2004
Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSAJ Kellogg Parsons, Michael K Brawer, Carol D Cheli, et al.
Urology|April 19, 2005
Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening programAl Baha Barqawi, Brian K Golden, Colin O'Donnell, et al.
Reviews in Urology|September 21, 2006
Chemoprevention strategies in the prostate: an overviewGary J Kelloff, Howard R Higley, Michael K Brawer, et al.
The Journal of Urology|October 22, 2011
Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancerMatthew R Smith, S Bruce Malkowicz, Michael K Brawer, et al.
Pageof 4